Less than half of patients ages 65 and older with metastatic non-small cell lung cancer received systemic treatment, according to a study published May 7 in JAMA Oncology. Researchers from Charleston-based Medical University of South Carolina, Memphis, Tenn.-based Baptist Cancer…
The Latest
Daraxonrasib, a drug that targets the genetic driver of most pancreatic cancers, extended clinical trial participants’ progression-free survival by a median of 8.5 months, according to a study published May 6 in The New England Journal of Medicine. Fifteen cancer…
Livonia, Mich.-based Trinity Health will invest $22.7 million in renovations at the Trinity Health Grand Rapids (Mich.) Richard J. Lacks Sr. Cancer Center. The cancer center will remain open during construction, which is expected to be completed in fall 2028,…
Wilmington, Del.-based ChristianaCare has appointed Deepak Vadehra, DO, chief of gastrointestinal oncology. Dr. Vadehra shared news of his appointment in a May 6 LinkedIn post. He was also appointed director of clinical trials and director of clinical research for solid…
Tampa, Fla.-based Moffitt Cancer Center recorded an operating income of $63.7 million (7.3% operating margin) during the third quarter of fiscal 2026, up from $40.2 million (5.2% margin) during the same period last year, according to its May 6 financial…
Researchers from Rochester, Minn.-based Mayo Clinic and Stanford (Calif.) Medicine have developed a blood test capable of mapping cancer cell ecosystems to predict immunotherapy response, according to a study published May 6 in Nature. Certain cell ecosystems, or neighborhoods, are…
The FDA has approved a companion diagnostic from Guardant Health to identify patients eligible for treatment with a targeted therapy developed by Pfizer and Arvinas. The blood-based test detects ESR1 mutations in patients with estrogen receptor-positive, HER2-negative advanced or metastatic…
Seattle-based Fred Hutch Cancer Center has appointed Chris Li, MD, PhD, senior vice president and director of its public health sciences division. Dr. Li also serves as the Helen G. Edson Endowed Chair for Breast Cancer Research, according to a…
Healthcare leaders are under pressure to prove the business impact of AI — not just fund more pilots. Boards want numbers. Operating teams want clarity. And finance leaders are being asked to quantify value in an area where benchmarks are…
Jun 9, 2026 11:00 AM - 12:00 PM CDT
Presented by:
Presenters
Andrew Mackenzie, FSA, CERA, MAAA
Chief Science Officer Arbital Health
Christine Rabenda
Chief Financial Officer UNC Health
Brady Priest
CEO Clover Care Services
Patients are more likely to participate in colorectal cancer screening if they have a strong relationship with their healthcare provider, according to a study published April 24 in Cancer Medicine. Researchers from Renton, Wash.-based Providence surveyed 1,798 patients in racially…